127 related articles for article (PubMed ID: 33733590)
1. Inhibition of osteoclast activities by SCPC bioceramic promotes osteoblast-mediated graft resorption and osteogenic differentiation.
El-Ghannam A; Nakamura M; Muguruza LB; Sarwar U; Hassan M; Fotawi RA; Horowitz R
J Biomed Mater Res A; 2021 Sep; 109(9):1714-1725. PubMed ID: 33733590
[TBL] [Abstract][Full Text] [Related]
2. Soluble silica inhibits osteoclast formation and bone resorption in vitro.
Mladenović Ž; Johansson A; Willman B; Shahabi K; Björn E; Ransjö M
Acta Biomater; 2014 Jan; 10(1):406-18. PubMed ID: 24016843
[TBL] [Abstract][Full Text] [Related]
3. Advanced bioceramic composite for bone tissue engineering: design principles and structure-bioactivity relationship.
El-Ghannam AR
J Biomed Mater Res A; 2004 Jun; 69(3):490-501. PubMed ID: 15127396
[TBL] [Abstract][Full Text] [Related]
4. Effects of exogenous phosphorus and silicon on osteoblast differentiation at the interface with bioactive ceramics.
Gupta G; Kirakodu S; El-Ghannam A
J Biomed Mater Res A; 2010 Dec; 95(3):882-90. PubMed ID: 20845489
[TBL] [Abstract][Full Text] [Related]
5. Effect of bioactive ceramic dissolution on the mechanism of bone mineralization and guided tissue growth in vitro.
El-Ghannam A; Ning CQ
J Biomed Mater Res A; 2006 Feb; 76(2):386-97. PubMed ID: 16270343
[TBL] [Abstract][Full Text] [Related]
6. Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro.
Wang L; Zhao R; Shi X; Wei T; Halloran BP; Clark DJ; Jacobs CR; Kingery WS
Bone; 2009 Aug; 45(2):309-20. PubMed ID: 19379851
[TBL] [Abstract][Full Text] [Related]
7. Biomaterial based treatment of osteoclastic/osteoblastic cell imbalance - Gelatin-modified calcium/strontium phosphates.
Kruppke B; Wagner AS; Rohnke M; Heinemann C; Kreschel C; Gebert A; Wiesmann HP; Mazurek S; Wenisch S; Hanke T
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109933. PubMed ID: 31499966
[TBL] [Abstract][Full Text] [Related]
8. Strontium substitution in apatitic CaP cements effectively attenuates osteoclastic resorption but does not inhibit osteoclastogenesis.
Schumacher M; Wagner AS; Kokesch-Himmelreich J; Bernhardt A; Rohnke M; Wenisch S; Gelinsky M
Acta Biomater; 2016 Jun; 37():184-94. PubMed ID: 27084107
[TBL] [Abstract][Full Text] [Related]
9. The surface microporosity of ceramic biomaterials influences the resorption capacity of osteoclasts.
Zimmer G; Rohrhofer A; Lewis K; Goessl A; Hoffmann O
J Biomed Mater Res A; 2013 Dec; 101(12):3365-71. PubMed ID: 23553950
[TBL] [Abstract][Full Text] [Related]
10. Effect of calcium phosphate phases affecting the crosstalk between osteoblasts and osteoclasts in vitro.
Shiwaku Y; Tsuchiya K; Xiao L; Suzuki O
J Biomed Mater Res A; 2019 May; 107(5):1001-1013. PubMed ID: 30684383
[TBL] [Abstract][Full Text] [Related]
11. Promotion of pro-osteogenic responses by a bioactive ceramic coating.
Aniket ; Young A; Marriott I; El-Ghannam A
J Biomed Mater Res A; 2012 Dec; 100(12):3314-25. PubMed ID: 22733626
[TBL] [Abstract][Full Text] [Related]
12. High porous titanium scaffolds showed higher compatibility than lower porous beta-tricalcium phosphate scaffolds for regulating human osteoblast and osteoclast differentiation.
Hirota M; Hayakawa T; Shima T; Ametani A; Tohnai I
Mater Sci Eng C Mater Biol Appl; 2015 Apr; 49():623-631. PubMed ID: 25686991
[TBL] [Abstract][Full Text] [Related]
13. A bioceramic with enhanced osteogenic properties to regulate the function of osteoblastic and osteocalastic cells for bone tissue regeneration.
Roohani-Esfahani SI; No YJ; Lu Z; Ng PY; Chen Y; Shi J; Pavlos NJ; Zreiqat H
Biomed Mater; 2016 Jun; 11(3):035018. PubMed ID: 27305523
[TBL] [Abstract][Full Text] [Related]
14. Mussel-inspired bioceramics with self-assembled Ca-P/polydopamine composite nanolayer: preparation, formation mechanism, improved cellular bioactivity and osteogenic differentiation of bone marrow stromal cells.
Wu C; Han P; Liu X; Xu M; Tian T; Chang J; Xiao Y
Acta Biomater; 2014 Jan; 10(1):428-38. PubMed ID: 24157695
[TBL] [Abstract][Full Text] [Related]
15. The prenyl group contributes to activities of phytoestrogen 8-prenynaringenin in enhancing bone formation and inhibiting bone resorption in vitro.
Ming LG; Lv X; Ma XN; Ge BF; Zhen P; Song P; Zhou J; Ma HP; Xian CJ; Chen KM
Endocrinology; 2013 Mar; 154(3):1202-14. PubMed ID: 23389955
[TBL] [Abstract][Full Text] [Related]
16. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
17. Gelatine modified monetite as a bone substitute material: An in vitro assessment of bone biocompatibility.
Kruppke B; Farack J; Wagner AS; Beckmann S; Heinemann C; Glenske K; Rößler S; Wiesmann HP; Wenisch S; Hanke T
Acta Biomater; 2016 Mar; 32():275-285. PubMed ID: 26732518
[TBL] [Abstract][Full Text] [Related]
18. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
[TBL] [Abstract][Full Text] [Related]
19. Injectable calcium phosphate ceramics prevent osteoclastic differentiation and osteoporotic bone loss: Potential applications for regional osteolysis.
Heng S; Lu Z; Liu Q; Jiang T; He M; Song F; Zhao J; Zheng L
Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110691. PubMed ID: 32204116
[TBL] [Abstract][Full Text] [Related]
20. Dissolution behavior of CaO-MgO-SiO
Zhang M; Chen X; Pu X; Liao X; Huang Z; Yin G
J Biomed Mater Res A; 2017 Nov; 105(11):3159-3168. PubMed ID: 28707315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
